title: Evaluation of bronchospasmolytic, antiallergic, anti-inflammatory, mucolytic and antitussive activities of decasilate in experimental models.
abstract: The bronchospasmolytic, antiallergic, anti-inflammatory, mucolytic and antitussive activities of 8-(2-phenylethyl)-1-oxa-diazaspiro[4,5]decan-2-one 2-tiophenecarboxylate (decasilate, CAS 76652-72-7) have been evaluated using different experimental models. 1. Decasilate showed a remarkable spasmolytic activity against histamine-induced contractions in the isolated guinea-pig tracheal preparation with an IC50 of 2.7 x 10(-6) mol/l. In addition, the oral administration of decasilate (5-30 mg.kg-1) significantly reduced the histamine aerosol-induced bronchospasm in guinea-pigs. 2. Decasilate had a preventive effect against antigen-induced contractions of ileum segments from sensitized guinea-pigs (EC50 8.0 x 10(-6) mol/l) and relaxed them when added after the antigen challenge (IC50 9.5 x 10(-7) mol/l). 3. Both carrageenin- and dextran-induced rat hind paw oedemas were significantly reduced by the oral administration of decasilate with ED50 values of 169.5 and 34.5 mg.kg-1, respectively. However, it was ineffective against the cotton pellet-induced granuloma in the rat. 4. Furthermore, decasilate had a significant mucolytic activity in rabbits and reduced the number of tussive seizures induced by an aerosol of citric acid in guinea-pigs. The pharmacological profile of decasilate suggests that it might be useful in the management of chronic bronchitis.
authors.affiliation: Research Department, FAES S.A., Bilbao, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Ucelay
authors.forename: L
authors.initials: L
authors.lastname: Labeaga
authors.forename: A
authors.initials: A
authors.lastname: Orjales
authors.forename: L
authors.initials: L
authors.lastname: Zubiaur
authors.forename: A
authors.initials: A
authors.lastname: Quintana
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000996:Antitussive Agents; D001993:Bronchodilator Agents / Q000494:pharmacology*; D005100:Expectorants; D005260:Female; D006168:Guinea Pigs; D006967:Hypersensitivity / Q000188:drug therapy; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D010276:Parasympatholytics; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D013141:Spiro Compounds / Q000494:pharmacology*; D013876:Thiophenes / Q000494:pharmacology*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000996:Antitussive Agents; D001993:Bronchodilator Agents; D005100:Expectorants; D010276:Parasympatholytics; D013141:Spiro Compounds; D013876:Thiophenes; C070900:decasilate